Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models

Stephen B. Willingham, Po Y. Ho, Andrew Hotson, Craig Hill, Emily C. Piccione, Jessica Hsieh, Liang Liu, Joseph J. Buggy, Ian McCaffery and Richard A. Miller
Stephen B. Willingham
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: swillingham@corvuspharma.com
Po Y. Ho
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Hotson
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig Hill
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily C. Piccione
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Hsieh
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jessica Hsieh
Liang Liu
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph J. Buggy
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian McCaffery
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A. Miller
Corvus Pharmaceuticals, Burlingame, California.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/2326-6066.CIR-18-0056 Published October 2018
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: August 2018 to January 2021

AbstractFull-text HTMLPDF
Total195072464671

Cited By

Article Information

Volume 6, Issue 10, pp. 1136-1149

DOI 
https://doi.org/10.1158/2326-6066.CIR-18-0056
PubMed 
30131376

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received February 5, 2018
  • Revision received June 12, 2018
  • Accepted August 17, 2018
  • Published first August 21, 2018.

Article Versions

  • Previous version (August 21, 2018 - 06:51).
  • Previous version (September 24, 2018 - 06:59).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2018 American Association for Cancer Research.

Author Information

  1. Stephen B. Willingham*,
  2. Po Y. Ho,
  3. Andrew Hotson,
  4. Craig Hill,
  5. Emily C. Piccione,
  6. Jessica Hsieh,
  7. Liang Liu,
  8. Joseph J. Buggy,
  9. Ian McCaffery, and
  10. Richard A. Miller
  1. Corvus Pharmaceuticals, Burlingame, California.
  1. ↵*Corresponding Author:
    Stephen B. Willingham, Corvus Pharmaceuticals, 863 Mitten Road, Suite 102, Burlingame, CA 94010. Phone: 650-900-4527; Fax: 844-463-2039; E-mail: swillingham{at}corvuspharma.com
View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 6 (10)
October 2018
Volume 6, Issue 10
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
Stephen B. Willingham, Po Y. Ho, Andrew Hotson, Craig Hill, Emily C. Piccione, Jessica Hsieh, Liang Liu, Joseph J. Buggy, Ian McCaffery and Richard A. Miller
Cancer Immunol Res October 1 2018 (6) (10) 1136-1149; DOI: 10.1158/2326-6066.CIR-18-0056

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
Stephen B. Willingham, Po Y. Ho, Andrew Hotson, Craig Hill, Emily C. Piccione, Jessica Hsieh, Liang Liu, Joseph J. Buggy, Ian McCaffery and Richard A. Miller
Cancer Immunol Res October 1 2018 (6) (10) 1136-1149; DOI: 10.1158/2326-6066.CIR-18-0056
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • CD28 Mutation Enhances CAR T-cell Function
  • ICV-Delivered CD19-CAR T Cells for CNS and Systemic Lymphoma
  • Activin A Mediates Radiation-Induced Antitumor Immunity
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement